HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[News and perspectives in uterine fibroids radiotherapy].

Abstract
Uterine artery embolization (UAE) represents radiological treatment of uterine fibroids. It is highly effective and safe mainly in premenopausal patients with symptomatic fibroids and represents an alternative to hysterectomy in a group of women not suitable for minimally invasive surgical treatment (LAVH) and women desiring uterus sparing therapy. The future of UAE lies in optimal selection of patients based on volume-shrinkage prediction and fertility outcome. The second group is represented by methods based on direct fibroid tissue destruction using specific energy under MRI or UZ guidance. The common aim of these two groups is the volume shrinkage as well as the symptomatic relief. The second group is represented by radiofrequency ablation, focused ultrasound surgery, interstitial laser ablation and cryotherapy. Based on their non-surgical, percutaneous approach these can be classified as minimally-invasive methods. The second group of methods is suitable only for patients with the absence of any desire for child bearing due to the absence of their long-term outcome data.
AuthorsK Kubínová, M Mára, P Horák, R Kríz, J Masková, D Kuzel
JournalCeská gynekologie / Ceská lékarská spolecnost J. Ev. Purkyne (Ceska Gynekol) Vol. 74 Issue 1 Pg. 22-6 (Feb 2009) ISSN: 1210-7832 [Print] Czech Republic
Vernacular TitleNovinky a perspektivy v radiologické lécbe delozních myomů.
PMID19408851 (Publication Type: English Abstract, Journal Article, Review)
Topics
  • Female
  • Humans
  • Leiomyoma (radiography, therapy)
  • Radiography, Interventional
  • Uterine Neoplasms (radiography, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: